1. answerboy79
2. wjohenning2756
3. mevol77
4. spottedgecko7
5. jcherolis
1.wjohenning2756 02/21/2018
Announces publication of the results from the Phase 1
2.answerboy79 02/21/2018
I bought in over a year ago
3.spottedgecko7 01/08/2018
Facts - TG Therapeutics and Jiangsu Hengrui Medicine Announce Global License Agreement for Development and Commercialization of Novel BTK Inhibitor Program for the Treatment of Hematologic Malignancie
4.mevol77 04/24/2018
TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the American Academy of Neurology 70th Annual Meeting
5.zbzapp95 02/21/2018
Seems like $20 getting closer every day
6.jcherolis 06/04/2018
Top Analyst Weighs in on TG Therapeutics (TGTX) Following Encouraging ASCO Update
7.answerboy79 02/21/2018
The bid is strong. Good depth
8.answerboy79 02/05/2018
More details
9.spottedgecko7 02/21/2018
watching for more {Image}
10.answerboy79 02/02/2018
Announces results from the Phase 2 multicenter trial of ublituximab (TG-1101) in relapsing forms of Multiple…
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW